Replies to post #114 on UniCycive Therapeutics Inc (UNCY)

[Whalatane]

Thx. Got stopped out of half of my UNCY position . With 90 patients to enroll now ( not 60 as per original design ) this Co needs to raise cash to complete the trial and release results ...probably in Q3 now ...not Q2 as claimed in most recent PR
JMO
Kiwi

[Whalatane]

Re UNCY. Orphan drug designation

Orphan drug status (designated by the FDA) gives a company exclusive marketing rights for a seven-year period, along with other benefits to recoup the costs of researching and developing drugs to treat rare diseases.
The Orphan Drug Act was designed to encourage companies to develop drugs for rare diseases.

Kiwi

[Whalatane]

RMB. I added some back in on the Orphan drug designation. I still think they need to raise cash to fund completion of their pivotal trial ...but this new designation should help them raise funds on better terms.
JMO
Kiwi